Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes.

Thrombotic microangiopathy aHUS abortion cTMA complement system delivery live birth miscarriage neonatal outcomes pregnancy pregnancy counseling

Journal

Kidney medicine
ISSN: 2590-0595
Titre abrégé: Kidney Med
Pays: United States
ID NLM: 101756300

Informations de publication

Date de publication:
Jul 2023
Historique:
medline: 26 7 2023
pubmed: 26 7 2023
entrez: 26 7 2023
Statut: epublish

Résumé

Pregnancy, delivery, and neonatal outcomes in women with complement-mediated thrombotic microangiopathy (cTMA) have not been well described. A better understanding of these outcomes is necessary to provide women with competent pregnancy counseling. Cohort study. Women with a history of cTMA and pregnancies enrolled into the Vienna thrombotic microangiopathy cohort. New onset or relapses of cTMA. Pregnancy, delivery, and neonatal outcomes of pregnancies in women (a) before cTMA manifestation, (b) complicated by pregnancy-associated cTMA (P-cTMA), and (c) after first manifestation of cTMA or P-cTMA. Mixed models were used to adjust the comparison of pregnancy, delivery, and neonatal outcomes between conditions (before, with, and after cTMA) for repeated pregnancies using the mother's ID as random factor. In addition, the fixed factors, mother's age and neonate's sex, were used for adjustment. For (sex-adjusted and age-adjusted) centile outcomes, only the mother's age was used. Adjusted odds ratios were derived from a generalized linear mixed model with live birth as the outcome. Least squares means and pairwise differences between them were derived from the linear mixed models for the remaining outcomes. 28 women reported 74 pregnancies. Despite higher rates of fetal loss before the diagnosis of P-cTMA and preterm births with P-cTMA, most of the women were able to conceive successfully. Neonatal development in all 3 conditions of pregnancies was excellent. Pregnancy and neonatal outcomes were better in women with a pregnancy after the diagnosis of cTMA. Although our data set comprises a considerable number of 74 pregnancies, the effective sample size is lower because only 28 mothers with multiple pregnancies were observed. The statistical power for detecting clinically relevant effects was probably low. A recall bias for miscarriages cannot be ruled out. Prepregnancy counseling of women with a history of cTMA can be supportive of their desire to become pregnant.

Identifiants

pubmed: 37492116
doi: 10.1016/j.xkme.2023.100669
pii: S2590-0595(23)00085-7
pmc: PMC10363558
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100669

Informations de copyright

© 2023 The Authors.

Références

Nephrol Dial Transplant. 2016 Dec;31(12):2122-2130
pubmed: 27587606
Nephron. 2022;146(1):1-10
pubmed: 34515154
Clin Kidney J. 2019 Apr 21;12(3):333-337
pubmed: 31198225
Clin Kidney J. 2022 Apr 12;15(7):1429-1430
pubmed: 35756730
Front Immunol. 2020 Jul 31;11:1681
pubmed: 32849586
Blood. 2020 Nov 5;136(19):2103-2117
pubmed: 32808006
Kidney Int. 2018 Feb;93(2):450-459
pubmed: 28911789
Nephrol Dial Transplant. 2020 Sep 1;35(9):1538-1546
pubmed: 30805631
Br J Haematol. 2020 Aug;190(3):442-449
pubmed: 32342491
J Am Soc Nephrol. 2010 May;21(5):859-67
pubmed: 20203157
Prev Med. 1978 Dec;7(4):561-3
pubmed: 756005
Clin Kidney J. 2020 Aug 20;14(4):1255-1260
pubmed: 33841869
Obstet Gynecol. 2020 Jan;135(1):46-58
pubmed: 31809447
BMJ. 2019 Mar 20;364:l869
pubmed: 30894356
J Clin Med. 2020 Mar 31;9(4):
pubmed: 32244370
Eur J Intern Med. 2020 Mar;73:51-58
pubmed: 31791575
BMC Pediatr. 2013 Apr 20;13:59
pubmed: 23601190
Acta Paediatr Suppl. 2006 Apr;450:76-85
pubmed: 16817681
J Nephrol. 2022 Mar;35(2):451-461
pubmed: 33599971
Biol Sex Differ. 2020 May 11;11(1):26
pubmed: 32393396
Kidney Med. 2020 Feb 22;2(2):213-217
pubmed: 32734241
J Am Soc Nephrol. 2018 Mar;29(3):1020-1029
pubmed: 29282226
Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1237-1247
pubmed: 28596415

Auteurs

Natalja Haninger-Vacariu (N)

Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Andreas Gleiss (A)

Center for Medical Science, Institute of Clinical Biometrics, Medical University of Vienna, Vienna, Austria.

Martina Gaggl (M)

Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Christof Aigner (C)

Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Renate Kain (R)

Department of Pathology, Medical University of Vienna, Vienna, Austria.

Zoltán Prohászka (Z)

Research Laboratory, Department of Internal Medicine and Hematology, and MTA-SE Research Group of Immunology and Hematology, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary.

Ágnes Szilágyi (Á)

Research Laboratory, Department of Internal Medicine and Hematology, and MTA-SE Research Group of Immunology and Hematology, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary.

Dorottya Csuka (D)

Research Laboratory, Department of Internal Medicine and Hematology, and MTA-SE Research Group of Immunology and Hematology, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary.

Georg A Böhmig (GA)

Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Raute Sunder-Plassmann (R)

Genetics Laboratory, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

Gere Sunder-Plassmann (G)

Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Alice Schmidt (A)

Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Classifications MeSH